2010 ACVIM Small Animal Consensus Statement on Leptospirosis: Diagnosis, Epidemiology, Treatment, and Prevention

Journal of Veterinary Internal Medicine

Volumn 25, Issue 1, 2011, Pages 1-13

  Sykes, J E ^a   Hartmann, K ^b   Lunn, K F ^c   Moore, G E ^d   Stoddard, R A ^e   Goldstein, R E ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c Department of Ecosystem Science and Sustainability   (United States)

^d PURDUE UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f Animal Health Diagnostic Center   (United States)

Author keywords

Hepatitis; Leptospira interrogans; Nephritis; Zoonosis

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE; BACTERIUM ANTIBODY; DOXYCYCLINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CONSENSUS; DOG; DOG DISEASE; ISOLATION AND PURIFICATION; LEPTOSPIRA; LEPTOSPIROSIS; MICROBIOLOGY; PRACTICE GUIDELINE; ZOONOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CONSENSUS; DOG DISEASES; DOGS; DOXYCYCLINE; LEPTOSPIRA; LEPTOSPIROSIS; PRACTICE GUIDELINES AS TOPIC; ZOONOSES;

ANIMALIA; CANIS FAMILIARIS; LEPTOSPIRA INTERROGANS;

EID: 78651248934     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0654.x     Document Type: Article

References (133)

1. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.
2. Rentko VT, Clark N, Ross LA, et al. Canine leptospirosis. A retrospective study of 17 cases. J Vet Intern Med 1992;6:235-244.
3. Alton GD, Berke O, Reid-Smith R, et al. Increase in seroprevalence of canine leptospirosis and its risk factors, Ontario 1998-2006. Can J Vet Res 2009;73:167-175.
4. Ko AI, Goarant C, Picardeau M. Leptospira: The dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 2009;7:736-747.
5. Perolat P, Chappel RJ, Adler B, et al. Leptospira fainei sp. nov., isolated from pigs in Australia. Int J Syst Bacteriol 1998;48 (Part 3):851-858.
6. Ganoza CA, Matthias MA, Saito M, et al. Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis 4:e612.
7. Zakeri S, Khorami N, Ganji ZF, et al. Leptospira wolffii, a potential new pathogenic Leptospira species detected in human, sheep and dog. Infect Genet Evol 10:273-277.
8. Silva EF, Cerqueira GM, Seyffert N, et al. Leptospira noguchii and human and animal leptospirosis, Southern Brazil. Emerg Infect Dis 2009;15:621-623.
9. Ortega-Pacheco A, Colin-Flores RF, Gutierrez-Blanco E, et al. Frequency and type of renal lesions in dogs naturally infected with leptospira species. Ann NY Acad Sci 2008;1149:270-274.
10. Davis MA, Evermann JF, Petersen CR, et al. Serological survey for antibodies to Leptospira in dogs and raccoons in Washington State. Zoonoses Public Health 2008;55:436-442.
11. Campbell RS. Canine leptospirosis. Aust Vet J 2007;85:168.
12. Miller RI, Ross SP, Sullivan ND, et al. Clinical and epidemiological features of canine leptospirosis in North Queensland. Aust Vet J 2007;85:13-19.
13. Goldstein RE, Lin RC, Langston CE, et al. Influence of infecting serogroup on clinical features of leptospirosis in dogs. J Vet Intern Med 2006;20:489-494.
14. Geisen V, Stengel C, Brem S, et al. Canine leptospirosis infections-clinical signs and outcome with different suspected Leptospira serogroups (42 cases). J Small Anim Pract 2007;48:324-328.
15. Ahmed N, Devi SM, Valverde Mde L, et al. Multilocus sequence typing method for identification and genotypic classification of pathogenic Leptospira species. Ann Clin Microbiol Antimicrob 2006;5:28.
16. Adin CA, Cowgill LD. Treatment and outcome of dogs with leptospirosis: 36 cases (1990-1998). J Am Vet Med Assoc 2000;216:371-375.
17. Greenlee JJ, Alt DP, Bolin CA, et al. Experimental canine leptospirosis caused by Leptospira interrogans serovars pomona and bratislava. Am J Vet Res 2005;66:1816-1822.
18. Greenlee JJ, Bolin CA, Alt DP, et al. Clinical and pathologic comparison of acute leptospirosis in dogs caused by two strains of Leptospira kirschneri serovar grippotyphosa. Am J Vet Res 2004;65:1100-1107.
19. Birnbaum N, Barr SC, Center SA, et al. Naturally acquired leptospirosis in 36 dogs: Serological and clinicopathological features. J Small Anim Pract 1998;39:231-236.
20. Kohn B, Steinicke K, Arndt G, et al. Pulmonary abnormalities in dogs with leptospirosis. J Vet Intern Med 2010;24:1277-1282.
21. Minke JM, Bey R, Tronel JP, et al. Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine. Vet Microbiol 2009;137:137-145.
22. Townsend WM, Stiles J, Krohne SG. Leptospirosis and panuveitis in a dog. Vet Ophthalmol 2006;9:169-173.
23. Baumann D, Fluckiger M. Radiographic findings in the thorax of dogs with leptospiral infection. Vet Radiol Ultrasound 2001;42:305-307.
24. Croda J, Neto AN, Brasil RA, et al. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin Microbiol Infect 2010;16:593-599.
25. Trivedi SV, Vasava AH, Patel TC, et al. Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis. Indian J Crit Care Med 2009;13:79-84.
26. Mastrorilli C, Dondi F, Agnoli C, et al. Clinicopathologic features and outcome predictors of Leptospira interrogans Australis serogroup infection in dogs: A retrospective study of 20 cases (2001-2004). J Vet Intern Med 2007;21:3-10.
27. Wagenaar JF, Goris MG, Sakundarno MS, et al. What role do coagulation disorders play in the pathogenesis of leptospirosis? Trop Med Int Health 2007;12:111-122.
28. Abgueguen P, Delbos V, Blanvillain J, et al. Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France. J Infect 2008;57:171-178.
29. Rossetti CA, Liem M, Samartino LE, et al. Buenos Aires, a new Leptospira serovar of serogroup Djasiman, isolated from an aborted dog fetus in Argentina. Vet Microbiol 2005;107:241-248.
30. Ellis WA. Leptospirosis. J Small Anim Pract 1986;27:683-692.
31. Harkin KR, Gartrell CL. Canine leptospirosis in New Jersey and Michigan: 17 cases (1990-1995). J Am Anim Hosp Assoc 1996;32:495-501.
32. Magaldi AJ, Yasuda PN, Kudo LH, et al. Renal involvement in leptospirosis: A pathophysiologic study. Nephron 1992;62:332-339.
33. Bishop L, Strandberg JD, Adams RJ, et al. Chronic active hepatitis in dogs associated with leptospires. Am J Vet Res 1979;40:839-844.
34. Adamus C, Buggin-Daubie M, Izembart A, et al. Chronic hepatitis associated with leptospiral infection in vaccinated Beagles. J Comp Pathol 1997;117:311-328.
35. Boomkens SY, Slump E, Egberink HF, et al. PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol 2005;108:49-55.
36. Trevejo RT, Rigau-Perez JG, Ashford DA, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis 1998;178:1457-1463.
37. Agunloye CA, Nash AS. Investigation of possible leptospiral infection in cats in Scotland. J Small Anim Pract 1996;37:126-129.
38. Larsson CE, Santa Rosa CA, Hagiwara MK, et al. Prevalence of feline leptospirosis: Serologic survey and attempts of isolation and demonstration of the agent. Int J Zoonoses 1984;11L:161-169.
39. Mylonakis ME, Bourtzi-Hatzopoulou E, Koutinas AF, et al. Leptospiral seroepidemiology in a feline hospital population in Greece. Vet Rec 2005;156:615-616.
40. Rees HG. Leptospirosis in a cat. NZ Vet J 1964;12:64.
41. Mason RW, King SJ, McLachlan NM. Suspected leptospirosis in two cats. Aust Vet J 1972;48:622-623.
42. Bryson DJ, Ellis WA. Leptospirosis in a British domestic cat. J Small Anim Pract 1976;17:459-465.
43. Hemsley LA. Leptospira canicola and chronic nephritis in cats. Vet Rec 1956;68:300-301.
44. Fessler JF, Morter RL. Experimental feline leptospirosis. Cornell Vet 1964;54:176-190.
45. Larsson CE, Santa Rosa CA, Larrson MH, et al. Laboratory and clinical features of experimental feline leptospirosis. Int J Zoonoses 1985;12:111-119.
46. Pappas G, Papadimitriou P, Siozopoulou V, et al. The globalization of leptospirosis: Worldwide incidence trends. Int J Infect Dis 2008;12:351-357.
47. Moore GE, Guptill LF, Glickman NW, et al. Canine leptospirosis, United States, 2002-2004. Emerg Infect Dis 2006;12:501-503.
48. Brown CA, Roberts AW, Miller MA, et al. Leptospira interrogans serovar grippotyphosa infection in dogs. J Am Vet Med Assoc 1996;209:1265-1267.
49. Cole JR Jr., Sangster LT, Sulzer CR, et al. Infections with Encephalitozoon cuniculi and Leptospira interrogans, serovars Grippotyphosa and Ballum, in a kennel of foxhounds. J Am Vet Med Assoc 1982;180:435-437.
50. Zaǐtsev SV, Chernukha IuG, Evdokimova OA, et al. Survival rate of Leptospira pomona in the soil at a natural leptospirosis focus. Zh Mikrobiol Epidemiol Immunobiol 1989;2:64-68.
51. Meeyam T, Tablerk P, Petchanok B, et al. Seroprevalence and risk factors associated with leptospirosis in dogs. Southeast Asian J Trop Med Public Health 2006;37:148-153.
52. Sugunan AP, Vijayachari P, Sharma S, et al. Risk factors associated with leptospirosis during an outbreak in Middle Andaman, India. Indian J Med Res 2009;130:67-73.
53. Stern EJ, Galloway R, Shadomy SV, et al. Outbreak of leptospirosis among adventure race participants in Florida. Clin Infect Dis 2005;50:843-849.
54. Murhekar MV, Sugunan AP, Vijayachari P, et al. Risk factors in the transmission of leptospiral infection. Indian J Med Res 1998;107:218-223.
55. Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002;34:1593-1599.
56. Ward MP. Seasonality of canine leptospirosis in the United States and Canada and its association with rainfall. Prev Vet Med 2002;56:203-213.
57. Gautam R, Guptill LF, Wu CC, et al. Spatial and temporal-spatial clustering of overall and serovar-specific Leptospira microscopic agglutination test (MAT) seropositivity among dogs in the United States from 2000 through 2007. Prev Vet Med 2010;96:122-131.
58. Ghneim GS, Viers JH, Chomel BB, et al. Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosis. Vet Res 2007;38:37-50.
59. Ward MP, Guptill LF, Wu CC. Evaluation of environmental risk factors for leptospirosis in dogs: 36 cases (1997-2002). J Am Vet Med Assoc 2004;225:72-77.
60. Ward MP, Glickman LT, Guptill LE. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). J Am Vet Med Assoc 2002;220:53-58.
61. Adler H, Vonstein S, Deplazes P, et al. Prevalence of Leptospira spp. in various species of small mammals caught in an inner-city area in Switzerland. Epidemiol Infect 2002;128:107-109.
62. Saravanan R, Rajendra P, Garajan SP. Clinical, bacteriologic and histopathologic studies on induced leptospirosis in stray dog pups. Indian J Pathol Microbiol 1999;42:463-469.
63. McIntyre WI, Montgomery GL. Renal lesions in Leptospira canicola infection in dogs. J Pathol Bacteriol 1952;64:145-160.
64. Monahan AM, Callanan JJ, Nally JE. Review paper: Host-pathogen interactions in the kidney during chronic leptospirosis. Vet Pathol 2009;46:792-799.
65. Hubbert WT, Shotts EB. Leptospirosis in kennel dogs. J Am Vet Med Assoc 1966;148:1152-1159.
66. Ward MK, McDaniel MB, Tatum HW, et al. An epidemic of canicola fever in man with the demonstration of Leptospira canicola infection in dogs, swine, and cattle. Am J Hyg 1956;64:59-69.
67. Brod CS, Aleixo JA, Jouglard SD, et al. Evidence of dog as a reservoir for human leptospirosis: A serovar isolation, molecular characterization and its use in a serological survey. Rev Soc Bras Med Trop 2005;38:294-300.
68. Jimenez-Coello M, Ortega-Pacheco A, Guzman-Marin E, et al. Stray dogs as reservoirs of the zoonotic agents Leptospira interrogans, Trypanosoma cruzi, and Aspergillus spp. in an urban area of Chiapas in southern Mexico. Vector Borne Zoonotic Dis 2010;10:135-141.
69. Maciel EA, de Carvalho AL, Nascimento SF, et al. Household transmission of leptospira infection in urban slum communities. PLoS Negl Trop Dis 2008;2:e154.
70. Meyer KF. The diagnosis of leptospirosis: Weil's disease and Canicola Fever. Cal West Med 1939;51:294.
71. Newman JP. Studies of canine leptospirosis. I. Evaluation of laboratory diagnostic procedures. II. Serologic determination of the incidence of latent infection in the Lansing, Michigan area. Am J Vet Res 1950;11:405-411.
72. Feigin RD, Lobes LA, Anderson D, et al. Human leptospirosis from immunized dogs. Ann Intern Med 1973;79:777-785.
73. Richardson DJ, Gauthier JL. A serosurvey of leptospirosis in Connecticut peridomestic wildlife. Vector Borne Zoonotic Dis 2003;3:187-193.
74. Low DG, Hiatt CW, Gleiser CA, et al. Experimental canine leptospirosis. I. Leptospira icterohaemorrhagiae infections in immature dogs. J Infect Dis 1956;98:249-259.
75. Yoder HW, Bergman EN, Gleiser CA. Experimental canine leptospirosis. IV. Evaluation of selected antibiotics in the therapy of acute experimental Leptospira icterohemorrhagiae infections in immature dogs. J Infect Dis 1957;100:257-267.
76. Taylor PL, Hanson LE, Simon J. Serologic, pathologic, and immunologic features of experimentally induced leptospiral nephritis in dogs. Am J Vet Res 1970;31:1033-1049.
77. Navarro CE, Kociba GJ, Kowlaski JJ. Serum biochemical changes in dogs with experimental Leptospira interrogans serovar icterohaemorrhagiae infection. Am J Vet Res 1981;42:1125-1129.
78. Klaasen HL, Molkenboer MJ, Vrijenhoek MP, et al. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet Microbiol 2003;95:121-132.
79. Andre-Fontaine G, Branger C, Gray AW, et al. Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis. Vet Rec 2003;153:165-169.
80. Sonrier C, Branger C, Michel V, et al. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2000;19:86-94.
81. Nielsen JN, Cochran GK, Cassells JA, et al. Leptospira interrogans serovar Bratislava infection in two dogs. J Am Vet Med Assoc 1991;199:351-352.
82. Rühl-Fehlert CL, Brem S, Feller W, et al. Clinical, microbiological and pathological observations in laboratory Beagle dogs infected with leptospires of the serogroup Sejroe. Exp Toxicol Pathol 2000;52:201-207.
83. Prescott JF, McEwen B, Taylor J, et al. Resurgence of leptospirosis in dogs in Ontario: Recent findings. Can Vet J 2002;43:955-961.
84. Burth P, Younes-Ibrahim M, Goncalez FH, et al. Purification and characterization of a Na+, K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans. Infect Immun 1997;65:1557-1560.
85. Seguro AC, Lomar AV, Rocha AS. Acute renal failure of leptospirosis: Nonoliguric and hypokalemic forms. Nephron 1990;55:146-151.
86. Zaragoza C, Barrera R, Centeno F, et al. Characterization of renal damage in canine leptospirosis by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting of the urinary proteins. J Comp Pathol 2003;129:169-178.
87. Navarro CE, Kociba GJ. Hemostatic changes in dogs with experimental Leptospira interrogans serovar icterohaemorrhagiae infection. Am J Vet Res 1982;43:904-906.
88. Forrest LJ, O'Brien RT, Tremelling MS, et al. Sonographic renal findings in 20 dogs with leptospirosis. Vet Radiol Ultrasound 1998;39:337-340.
89. Chappel RJ, Goris M, Palmer MF, et al. Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis. J Clin Microbiol 2004;42:5484-5488.
90. Cerqueira GM, McBride AJ, Queiroz A, et al. Monitoring Leptospira strain collections: The need for quality control. Am J Trop Med Hyg 2010;82:83-87.
91. International Leptospirosis Society. International Leptospirosis MAT Proficiency Testing Scheme. Available at: Accessed June 21, 2010.
92. Galloway RL, Levett PN. Evaluation of a modified pulsed-gel electrophoresis approach for the identification of Leptospira serovars. Am J Trop Med Hyg 2008;78:628-632.
93. Barr SC, McDonough PL, Scipioni-Ball RL, et al. Serologic responses of dogs given a commercial vaccine against Leptospira interrogans serovar Pomona and Leptospira kirschneri serovar Grippotyphosa. Am J Vet Res 2005;66:1780-1784.
94. Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 2003;36:447-452.
95. World Health Organization. Human leptospirosis: Guidance for diagnosis, surveillance, and control. 2003. Available at: Accessed June 21, 2010.
96. Stoddard RA, Gee JE, Wilkins PP, et al. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn Microbiol Infect Dis 2009;64:247-255.
97. Harkin KR, Roshto YM, Sullivan JT. Clinical application of a polymerase chain reaction assay for diagnosis of leptospirosis in dogs. J Am Vet Med Assoc 2003;222:1224-1229.
98. Harkin KR, Roshto YM, Sullivan JT, et al. Comparison of polymerase chain reaction assay, bacteriologic culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogs. J Am Vet Med Assoc 2003;222:1230-1233.
99. Rojas P, Monahan AM, Schuller S, et al. Detection and quantification of leptospires in urine of dogs: A maintenance host for the zoonotic disease leptospirosis. Eur J Clin Microbiol Infect Dis 2010;29:1305-1309.
100. Cai CS, Zhu YZ, Zhong Y, et al. Development of O-antigen gene cluster-specific PCRs for rapid typing six epidemic serogroups of Leptospira in China. BMC Microbiol 2010;10:67.
101. Gaschen F. Canine leptospirosis. Proceedings of the World Small Animal Veterinary Association World Congress, Dublin, Ireland, August 20-24, 2008.
102. De Brito T, Menezes LF, Lima DM, et al. Immunohistochemical and in situ hybridization studies of the liver and kidney in human leptospirosis. Virchows Arch 2006;448:576-583.
103. Doungchawee G, Kositanont U, Niwetpathomwat A, et al. Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing. Clin Vaccine Immunol 2008;15:492-498.
104. Dey S, Mohan CM, Ramadass P, et al. Recombinant antigen-based dipstick ELISA for the diagnosis of leptospirosis in dogs. Vet Rec 2007;160:186-188.
105. Dey S, Madhan Mohan C, Ramadass P, et al. Recombinant antigen-based latex agglutination test for rapid serodiagnosis of leptospirosis. Vet Res Commun 2007;31:9-15.
106. Pappas G, Cascio A. Optimal treatment of leptospirosis: Queries and projections. Int J Antimicrob Agents 2006;28:491-496.
107. Suputtamongkol Y, Pongtavornpinyo W, Lubell Y, et al. Strategies for diagnosis and treatment of suspected leptospirosis: A cost-benefit analysis. PLoS Negl Trop Dis 2010;4:e610.
108. Watt G, Padre LP, Tuazon ML, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-435.
109. Panaphut T, Domrongkitchaiporn S, Vibhagool A, et al. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 2003;36:1507-1513.
110. Phimda K, Hoontrakul S, Suttinont C, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 2007;51:3259-3263.
111. Alexander AD, Rule PD. Penicillins, cephalosporins, and tetracyclines in the treatment of hamsters with fatal leptospirosis. Antimicrob Agents Chemother 1986;30:835-839.
112. Griffith ME, Moon JE, Johnson EN, et al. Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model. Antimicrob Agents Chemother 2007;51:2615-2617.
113. Truccolo J, Charavay F, Merien F, et al. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 2002;46:848-853.
114. Greene CE, Sykes JE, Brown CA, Hartmann K. Leptospirosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat, 3rd ed. St Louis, MO: Saunders Elsevier; 2006:402-417.
115. Cabana BE, Willhite LE, Bierwagen ME. Pharmacokinetic evaluation of the oral absorption of different ampicillin preparations in beagle dogs. Antimicrob Agents Chemother (Bethesda) 1969;9:35-41.
116. Cerqueira GM, Athanazio DA, Spichler AS, et al. Renal involvement in leptospirosis-new insights into pathophysiology and treatment. Braz J Infect Dis 2008;12:248-252.
117. Trivedi SV, Vasava AH, Bhatia LC, et al. Plasma exchange with immunosuppression in pulmonary alveolar hemorrhage due to leptospirosis. Indian J Med Res 2010;131:429-433.
118. Niwattayakul K, Kaewtasi S, Chueasuwanchai S, et al. An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis. Clin Microbiol Infect 2010;16:1207-1212.
119. Reis RB, Ribeiro GS, Felzemburgh RD, et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2008;2:e228.
120. Monahan AM, Miller IS, Nally JE. Leptospirosis: Risks during recreational activities. J Appl Microbiol 2009;107:707-716.
121. Benschop J, Heuer C, Jaros P, et al. Sero-prevalence of leptospirosis in workers at a New Zealand slaughterhouse. N Z Med J 2009;122:39-47.
122. Meites E, Jay MT, Deresinski S, et al. Reemerging leptospirosis, California. Emerg Infect Dis 2004;10:406-412.
123. Strugnell BW, Featherstone C, Gent M, et al. Weil's disease associated with the adoption of a feral rat. Vet Rec 2009;164:186.
124. Baer R, Turnberg W, Yu D, et al. Leptospirosis in a small animal veterinarian: Reminder to follow standardized infection control procedures. Zoonoses Public Health 2010;57:281-284.
125. Meyer KF, Stewart-Anderson B, Eddie B. "Canicola fever", a professional health hazard. J Am Vet Med Assoc 1938;93:332-333.
126. Meyer KF, Stewart-Anderson B. Epidemiology of leptospirosis. Am J Public Health Nations Health 1939;29:347-353.
127. Barkin RM, Glosser JW. Leptospirosis-an epidemic in children. Am J Epidemiol 1973;98:184-191.
128. Available at: Accessed August 21, 2010.
129. Guerra MA. Leptospirosis. J Am Vet Med Assoc 2009;234:472-478.
130. Kemenes F. Cross immunity studies on virulent strains of leptospira belonging to different serotypes. Z Immunitatsforsch Exp Ther 1964;127:209-229.
131. Plesko I, Lataste-Dorolle C. Intertype immunity relations of leptospira strains belonging to the 'Australia' serogroup. Biologia 1970;25:403-411.
132. Adler B, Faine S. The antibodies involved in the human immune response to leptospiral infection. J Med Microbiol 1978;11:387-400.
133. Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. J Am Vet Med Assoc 2005;227:1102-1108.